Tumor specific antigen appearance on normal cells during intermediate steps of viral carcinogenesis.
D000818:Animals; D000921:Antibody-Producing Cells; D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001853:Bone Marrow / Q000276:immunology; D002454:Cell Differentiation; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D003601:Cytotoxicity Tests, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006736:Horses / Q000276:immunology; D007106:Immune Sera; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D051379:Mice / Q000276:immunology; D008979:Moloney murine leukemia virus / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000382:microbiology; D009858:Oncogenic Viruses; D011828:Radiation Chimera; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014779:Virus Replication
D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D007106:Immune Sera